Enlitic, Inc., a San Francisco, CA-based developer of artificial intelligence (AI) software for doctors to diagnose patient conditions quickly and accurately, raised $25m in Series B-1 financing.
The round was led by Thorney Investment Group with participation from existing investors Capitol Health, Marubeni Corporation, Amplify Partners, The Jagen Group, and Regal Funds Management.
The company intends to use the funds to continue to build-out its AI software platform and to further grow its global presence with major regional partners in the healthcare industry.
Led by Kevin Lyman, Chief Executive Officer, and Anthony Upton, Chief Medical Officer, Enlitic provides a medical deep learning platform that leverages a team of practicing radiologists, data scientists, and software engineers to analyze a vast stream of healthcare data, including millions of clinical cases from cross-sector healthcare partners, to improve diagnostic accuracy, speed, and patient outcomes, as well as to accelerate pharmaceutical research and drug trials.
The company also has offices in New York and Sydney, Australia.
In conjunction with the funding, Enlitic appointed Lawrence Gozlan of The Jagen Group to the company’s board of directors, joining Lyman, Sunil Dhaliwal of Amplify partners, Andrew Harrison of Capitol Health, and Michael Sistenich, Chairman of the Board.